Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (131)

2024

  1. Association between exposure to air pollution and blood lipids in the general population of Spain

    European Journal of Clinical Investigation, Vol. 54, Núm. 2

  2. Capacidad del biomarcador suPAR para estratificar el pronóstico en pacientes atendidos en servicios de urgencias hospitalarios

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 1, pp. 17-24

  3. Cross-sectional association between severe periodontitis and diabetes mellitus: A nation-wide cohort study

    Journal of Clinical Periodontology, Vol. 51, Núm. 4, pp. 368-379

  4. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

  5. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

    Pediatric Research

  6. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

  7. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

2023

  1. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

    Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

    Actas Urologicas Espanolas

  4. Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439

  5. Cerebral Oximetry Monitoring in Extremely Preterm Infants

    New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511

  6. Change in physical activity related to admission for exacerbation in COPD patients

    Respiratory Medicine, Vol. 212

  7. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  8. Correction to: Predictors of short‑term COPD readmission (Internal and Emergency Medicine, (2022), 17, 5, (1481-1490), 10.1007/s11739-022-02948-4)

    Internal and Emergency Medicine

  9. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  10. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

  11. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  12. Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy

    Revista Espanola de Quimioterapia, Vol. 36, pp. 9-14

  13. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10